Always check the expiration date on your Ozempic pen and note the date you opened it
Suppose you're on a medication that typically costs $1,000 a month, but your health insurance pays most of the cost, so you're only responsible for a $150 monthly co-pay
Subgroup analysis revealed that subcutaneous injection of semaglutide is more likely to cause adverse events related to the endocrine system compared to oral administration
Cohort 2 At follow-up timepoints, 1.5 mg dulaglutide remained the most common, with a similar proportion of patients at 3 and 12 months post-index receiving this dosage formulation (85% and 87%, respectively)
Figure 3 6 Conclusion In summary, tirzepatide, a dual agonist of the GLP-1 and GIP receptors, shows promising potential for the management of obesity-related OSAS by promoting weight loss, improving metabolic function, and modulating inflammatory pathways